G6D-NAC (2.0 and 5.0 mg/kg) treatment showed a trend of decreased TSPO mRNA expression, but did not reach statistical significance (Fig. 4 i).
← all excerpts
Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
1
—
—